Stock_Titan Posted - 1 day ago

$OPRX OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report https://www.stocktitan.net/news/OPRX/optimize-rx-releases-2024-environmental-social-and-governance-esg-35d1wltoo5zd.html

epsguid Posted - 3 days ago

$OPRX reported earnings of $0.36, Earnings Whisper was $0.26 via @eWhispers #whisperbeat http://eps.sh/d/oprx

DonCorleone77 Posted - 3 days ago

$OPRX OptimizeRx sees FY24 revenue at least $100M, consensus $104.73M For the full year 2024, the Company is reiterating its 2024 guidance and expects revenue to be at least $100 million with an Adjusted EBITDA of at least $11 million.

DonCorleone77 Posted - 3 days ago

$OPRX OptimizeRx reports Q4 EPS 26c, consensus 32c Reports Q4 revenue $28.4M, consensus $27.53M. Will Febbo, OptimizeRx CEO commented, "Q4 of 2023 ended strongly, setting the Company up well for 2024. Our revenue for the quarter exceeded expectations, reaching $28.4 million, a 44% increase year-over-year. This was fueled by organic growth through our Dynamic Audience Activation Platform and a two-month contribution from the Medicx Health acquisition. Notably, our core HCP business saw an over 30% growth compared to Q4 2022."

Stock_Titan Posted - 3 days ago

$OPRX OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/OPRX/optimize-rx-reports-strong-fourth-quarter-and-full-year-2023-pq97fzn3l3yz.html

Stock_Titan Posted - 1 week ago

$OPRX OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row https://www.stocktitan.net/news/OPRX/optimize-rx-named-america-s-fastest-growing-company-for-fifth-year-hj7jlh4r96uw.html

TamaraPalmer Posted - 1 week ago

$FC $OPRX $WEBR All-- that you need to know. Shorts haven't covered a single share. Check it out below. 👇 Highly recommend everyone to follow them.,.,.,'🙏👇

ZFHoldings Posted - 2 weeks ago

$OPRX - https://investorplace.com/earning-results/2024/03/oprx-stock-earnings-optimizerx-for-q4-of-2023

ZFHoldings Posted - 2 weeks ago

$OPRX - RBC Capital maintains price target of $17.

ZFHoldings Posted - 2 weeks ago

$OPRX - OptimizerRx has been dropping for weeks despite positive earnings and a March 11th press release stating that their outlook for 2024 is approximately $100 million in net revenue when the company post approximately $70 million in gross revenue in 2023. The stock may pop within the week once OPRX posts their results on their webpage for investors.

Thestocktraderhubzee Posted - 2 weeks ago

$OPRX Stifel Maintains Buy on OptimizeRx, Maintains $13 Price Target

ZFHoldings Posted - 2 weeks ago

$OPRX OptimizerRX reported Q4 earnings of $28.4 million which beat the estimate of $26.47 million by 7.29% according to InvestorPlace.com. Not much information regarding the announcement from Friday. Now may be a good time to buy since the stock is down almost 30% since early March.

Jasooon Posted - 03/30/24

$OPRX, where was the ER? lol

Stock_Titan Posted - 03/25/24

$OPRX OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET https://www.stocktitan.net/news/OPRX/optimize-rx-sets-fourth-quarter-2023-conference-call-for-march-28-mzcqpmu9z0se.html

TheLastGoose Posted - 1 month ago

$OPRX add this since we finally get dip

TheLastGoose Posted - 1 month ago

$OPRX nice. It finally went down instead of up.

Jasooon Posted - 1 month ago

$OPRX, yikes, that’s like accounting 101 miss for this industry…

DonCorleone77 Posted - 1 month ago

$OPRX OptimizeRx cuts FY24 revenue view to at least $100M from at least $110M Consensus $110.67M. The company said, "During the audit of Medicx Health, it was determined that certain revenue streams for messages executed through Medicx Health's channel partners, historically recognized on a gross basis, will now be recognized on a net basis. Consequently, the Company is updating its revenue guidance for this change and now anticipates revenue to be at least $100 million for 2024 as a result of this gross-to-net accounting treatment. Importantly, the Company's adjusted EBITDA guidance remains unchanged, at greater than $11 million for 2024."

DonCorleone77 Posted - 1 month ago

$OPRX 2 of 2 - OptimizeRx backs FY23 revenue view at least $68M-$70M, consensus $69.85M ....During the audit of Medicx Health, it was determined that certain revenue streams for messages executed through Medicx Health's channel partners, historically recognized on a gross basis, will now be recognized on a net basis. Consequently, the Company is updating its revenue guidance for this change and now anticipates revenue to be at least $100 million for 2024 as a result of this gross-to-net accounting treatment. Importantly, the Company's adjusted EBITDA guidance remains unchanged, at greater than $11 million for 2024. Based on its preliminary, unaudited review, OptimizeRx estimates FY2023 revenue to exceed the range of $68-$70 million and adjusted EBITDA to be in the range of $3-$4 million, which is consistent with the Company's previously announced guidance."

DonCorleone77 Posted - 1 month ago

$OPRX 1 of 2 - OptimizeRx backs FY23 revenue view at least $68M-$70M, consensus $69.85M The company said, "The Company is working to complete its year end close and audit processes by the filing deadline for non-accelerated, smaller reporting companies. As part of that work, the Company is finalizing its financial results and year end audit that includes its October 2023 acquisition of Healthy Offers, Inc. (dba Medicx Health), the November 2023 operational realignment to focus on core business lines, and performing further remediation of the previously disclosed material weakness related to the testing and validation of internal processes tied to certain third-party vendors more fully described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022.The Company plans to hold a conference call on Thursday, March 28, 2024 to discuss its results for the fourth quarter and full-year periods ended December 31, 2023....

Stock_Titan Posted - 1 month ago

$OPRX OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 https://www.stocktitan.net/news/OPRX/optimize-rx-provides-an-update-on-the-timing-of-earnings-call-and-4cx9ibquvgg7.html

Doozio Posted - 1 month ago

is $oprx HIMS on eps during 🧠⏰?

Doozio Posted - 02/24/24

$OPRX chop chop huckleberries 🧠⏰.

TheLastGoose Posted - 02/21/24

$OPRX the last non-bot here posted 52% ago. This is one of the greatest Ponzi schemes ever and I’m just gonna hold light shares cause it’s actually such a sin.

TheLastGoose Posted - 02/21/24

$OPRX this will be like $70 in under a year for no reason at all.

TheLastGoose Posted - 02/21/24

$OPRX

Stock_Titan Posted - 02/21/24

$OPRX OptimizeRx to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/OPRX/optimize-rx-to-participate-in-upcoming-investor-nj272g0zrfgt.html

Last10K Posted - 01/26/24

$OPRX just filed with the SEC a Event for Officers, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/OPRX/0001213900-24-006959.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=OPRX

cctranscripts Posted - 3 months ago

OptimizeRx Corp's CEO just picked up 6,744 shares https://www.conferencecalltranscripts.org/summary/?id=12877671 $OPRX

tickeron Posted - 3 months ago

How do you think the market will react to this? $OPRX MACD Histogram turned positive on January 11, 2024. View odds of downtrend. https://srnk.us/go/4967156